(Q73112519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

A randomised dose-comparison trial of granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

0 references

Y Komada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Matsuyama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Takao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

T Hongo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Y Nishimura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Horibe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Sakurai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1095-1101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Intravenous granisetron--establishing the optimal dose. The Granisetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

The management of chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Improved therapy for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Granisetron as antiemetic therapy in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

Methodology of antiemetic trials: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900071-4

7 January 2021

10.1016/S0959-8049(99)00071-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10533454%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference